Several other equities analysts have also recently weighed in on HNR1. Barclays set a €104.90 ($129.51) target price on Hannover Re and gave the company a sell rating in a research note on Tuesday, April 10th. JPMorgan Chase set a €108.00 ($133.33) target price on Hannover Re and gave the company a neutral rating in a research note on Friday, January 5th. Goldman Sachs set a €111.00 ($137.04) target price on Hannover Re and gave the company a neutral rating in a research note on Wednesday, April 4th. Commerzbank reaffirmed a neutral rating on shares of Hannover Re in a research note on Monday, January 22nd. Finally, Nord/LB set a €118.00 ($145.68) target price on Hannover Re and gave the company a neutral rating in a research note on Tuesday, March 13th. Three equities research analysts have rated the stock with a sell rating, seventeen have issued a hold rating and four have assigned a buy rating to the company. Hannover Re currently has an average rating of Hold and an average price target of €110.60 ($136.54).
FRA:HNR1 opened at €114.10 ($140.86) on Thursday. Hannover Re has a fifty-two week low of €94.75 ($116.98) and a fifty-two week high of €116.37 ($143.67).
Hannover Re Company Profile
Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The Property & Casualty Reinsurance segment offers specialty lines comprising marine, aviation, facultative, credit, surety, and political risks reinsurance products; and treaty, catastrophe XL, and structured reinsurance, as well as insurance-linked securities.
Receive News & Ratings for Hannover Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hannover Re and related companies with MarketBeat.com's FREE daily email newsletter.